The FDA has approved more than 100 peptide-based drugs over the decades, including GLP-1 medications like semaglutide, which millions of people now take for weight loss
They are the result of 64 years of pharmaceutical expertise applied to a problem that the supplement industry has largely ignored
Looking to improve overall health at a cellular level and promote healthy aging
PON1 activity does not appear to show high specificity for liver damage as it is linked to a number of disease conditions like atherosclerosis, vasculitis and chronic hepatic damage
Chemically, these compounds are not related to naturally occurring cannabinoids, but their actions in the body create a high that resembles marijuana in some ways
G., Xia, S., Guerriero, J., Viney, N